在慢性TNF-α抑制的类风湿性关节炎患者中,皮下白血病是CD23阴性CLL/ SLL的初始表现
Nehaal Ahmed1, Saad Rashid2, Nadeem Kutaish3
1Division of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Case reports in hematology
|September 2, 2025
概括
这项病例研究突出显示了一种罕见的皮下白血病,一种慢性淋巴细胞白血病/小淋巴细胞淋巴瘤,最初发生在服用TNFα抑制剂的类风湿性关节炎患者中.
科学领域:
- 血液学
- 癌症学
- 关节病学
背景情况:
- 风湿性关节炎是一种慢性自身免疫性疾病.
- TNF-α抑制剂用于RA,但具有淋巴瘤风险.
- 慢性淋巴细胞白血病/小淋巴细胞淋巴瘤 (CLL/ SLL) 与外节或皮下白血病是罕见的.
研究的目的:
- 描述一种极为罕见的皮下白血病作为CLL/SLL的初始表现.
- 详细介绍TNFα抑制剂治疗的类风湿性关节炎患者的诊断结果.
主要方法:
- 一位使用TNFα抑制剂的RA患者的病例报告.
- 皮下质量的切除活检和流细胞测量分析.
- 针对特定标记物的免疫组织化学染色.
主要成果:
- 活检显示了与CLL/SLL一致的淋巴细胞表.
- 流细胞测量发现了CD23阴性,CD5,CD19,CD20,CD38,CD200,kappa轻链阳性单克隆B细胞群.
- 免疫检测显示CD43和LEF1的阳性,对循环-D1和SOX11的阴性.
结论:
- 这位患者被诊断为CLL/ SLL诱导的皮下白血病.
- 局部辐射疗法导致病变的消失.
- 在有淋巴瘤病史的患者中,应谨慎使用TNFα抑制剂.
更多相关视频
11:39Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking
Published on: October 23, 2019
11.6K
09:08Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
5.6K
相关概念视频
T Cell Types and Functions
3.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
Inflammatory Bowel Disease III: Crohn's Disease
75
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
75
